AgeX Therapeutics, ImStem Biotechnology sign non-binding letter of intent regarding investigational MSC candidate IMS001 for Covid-19

AgeX Therapeutics and ImStem Biotechnology have signed non-binding letter of intent regarding investigational MSC candidate IMS001 for Covid-19. (Credit: dianakuehn30010 from Pixabay)